0000000000535189

AUTHOR

Tim Wohlfarth

showing 2 related works from this author

The role of surgery in patients with primary metastatic breast cancer (PMBC) receiving monoclonal antibody treatment.

2014

1097 Background: Apart from the individual palliative need, the beneficial effect of surgically removing the primary tumor in PMBC on long-term outcomes, as suggested by retrospective series and me...

OncologyCancer Researchmedicine.medical_specialtyPrimary (chemistry)medicine.drug_classbusiness.industryMonoclonal antibodymedicine.diseaseMetastatic breast cancerPrimary tumorhumanitiesOncologyInternal medicinemedicineIn patientbusinessJournal of Clinical Oncology
researchProduct

Trastuzumab in Combination with Different First-Line Chemotherapies for Treatment of Her2-Positive Metastatic Gastric Cancer: Updated Findings from t…

2014

ABSTRACT Aim: The international phase III study ToGA has shown that trastuzumab (TRA) (Herceptin®) is effective in prolonging survival in HER2-positive metastatic gastric or gastro-oesophageal junction cancer (MGC). However, few data are available for TRA as part of routine clinical practice. Methods: This non-interventional observational study (NCT01220934) aims to evaluate the efficacy, safety and feasibility of TRA in previously untreated pts with HER2-positive MGC. Results: Between Apr 2010 and Apr 2014, we collected data from 360 pts. All pts were evaluable for safety. Baseline pt characteristics were as follows: median age 66 y (range 29–90); gender (male 74%; female 26%); ECOG PS (0:…

OncologyCisplatinmedicine.medical_specialtyNauseabusiness.industryHematologyChemotherapy regimenOxaliplatinCapecitabineRegimenOncologyDocetaxelFluorouracilInternal medicinemedicinemedicine.symptombusinessmedicine.drugAnnals of Oncology
researchProduct